Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Kass (Pittsburgh, United States of America), S. Strock (Pittsburgh, United States of America), M. Nouraie (Pittsburgh, United States of America), J. Chiarchiaro (Pittsburgh, United States of America), K. Veraldi (Pittsburgh, United States of America), Y. Zhang (Pittsburgh, United States of America), K. Gibson (Pittsburgh, United States of America). Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior. 5215

Member's Comments

No comment yet.

Related content which might interest you: Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Genetic Profiles of Clinical Features in Sarcoidosis Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype Year: 2018 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Unrevealed Structural, Functional and Immunological Pulmonary Changes Induced by Metabolic Syndrome in Elderly Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Analysis of Causes of Diagnostic Difficulties and Features of Clinical Course of Pulmonary Embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Severity of Bronchiectasis and Lung Functions Related with the Genotype of Primary Ciliary Dyskinesia Patients Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Clinical Utility of Different Methods In Diagnosis Of Pulmonary Cryptococosis In Patients Without HIV Infection Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Predictors of Progression in Patients with Pulmonary Sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Metered Cryospray Modulates Bronchial Epithelial Gene Expression in Patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Liquid biopsy for Chronic Thromboembolic Pulmonary Hypertension: Circulating microRNA profile by Next Generation Sequencing Source: International Congress 2017 – PAH and CTEPH Year: 2017